Role of Host Filamin Proteins in Regulating Filovirus Entry and Egress
宿主细丝蛋白在调节丝状病毒进入和排出中的作用
基本信息
- 批准号:10644499
- 负责人:
- 金额:$ 26.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-10 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:ActinsAffectAntibody TherapyAntiviral TherapyBAG3 geneBiochemicalBiological AssayCell FractionationCell SeparationCell divisionCell membraneCell physiologyCellsCellular MorphologyCessation of lifeComplexCytokinesisDevelopmentDisease OutbreaksEbolaEbola virusEyeFamilyFilopodiaFilovirusFutureGoalsHIV-1Host Defense MechanismHumanImmunologicsInfectionIntegrinsLaboratoriesLife Cycle StagesLinkLiquid substanceMagnetismMammalian CellMarburgvirusMediatingMembraneMicroscopyMolecularPathway interactionsProcessProteinsProteomeReagentRecombinantsRegulationRibonucleasesRoleSeminal fluidSiteSmall Interfering RNATestingTherapeutic InterventionTotal Internal Reflection FluorescentVesicleVesicular stomatitis Indiana virusViralViral Hemorrhagic FeversVirionVirusVirus AssemblyVirus DiseasesVirus ReplicationZoonosescell motilitychronic infectioncombatconfocal imagingcrosslinkdriving forceemerging pathogenextracellularfilamininsightlink proteinlong-term sequelaemembernonhuman primatenovelparticleprotein crosslinktraffickingubiquitin-protein ligasevirus host interaction
项目摘要
Filoviruses (Ebola [EBOV] and Marburg [MARV]) are zoonotic, emerging pathogens that cause sporadic and
global outbreaks of severe hemorrhagic fever in humans and non-human primates. As EBOV and MARV can
establish persistent infections in the CNS, semen, eye, and other immunologically privileged sites inaccessible
to antibody therapy, and their re-emergence can result in long-term sequelae and death, understanding of host
defense mechanisms that could lead to the development of new antiviral therapies is more critical than ever. Our
lab is at the forefront of identifying host proteins that interact both physically and functionally with the filovirus
VP40 matrix protein, the driving force for virus assembly and egress, to regulate these late stages of virus
replication. To better understand the functional filovirus-host interactome, our laboratory has focused on direct
interactions between the PPxY Late (L) domain motif conserved in the VP40 proteins of EBOV (eVP40) and
MARV (mVP40) and modular WW-domains from select host proteins. In addition to positive regulators of filovirus
egress, we have recently identified WW-domain interactors that negatively regulate VP40-mediated budding,
including YAP/TAZ, BAG3, and WWOX. While the impact of these negative regulators is likely multifactorial and
complex, we have made the intriguing observation that filamin B, a common downstream effector of YAP/TAZ
and BAG3, acts as a potential dual regulator of live EBOV/MARV infectivity/entry and live EBOV/MARV egress.
As dual role regulation of key stages at opposite ends of the filovirus lifecycle is novel and unexpected, the
ultimate goal of this proposal is to determine how host protein filamin B mechanistically impacts the filovirus
lifecycle. Filamins are a family of actin crosslinking/stabilizing proteins that regulate actin dynamics at the plasma
membrane to control cell migration and morphology, vesicle trafficking, macropinocytosis, and cell division.
Notably, macropinocytosis
macropinosomes
is
(MPs) that are densely coated with actin, filamin, and filamin-associated proteins
a key entry pathway for filoviruses, as these viruses enter the cell in vesicles
termed
. In addition,
filamins are linked to cellular processes that mimic virion formation and/or egress such as filopodia formation,
cell migration, and cytokinesis. Thus, we hypothesize that filamin B regulates infectivity/entry of filoviruses
through effects on macropinocytosis, and regulates filovirus budding through effects on egress of filopodia-like
filovirus particles. In this exploratory proposal, we propose to investigate the mechanisms by which filamin
regulates filovirus infectivity/entry (Aim 1) and egress (Aim 2). Results from these studies will impact the field by
identifying a novel host protein(s) whose expression modulates two critical and opposite steps in the filovirus
lifecycle; entry and exit, as well as providing a better fundamental understanding of the functional filovirus-host
interactome and host defense mechanisms that could lead to the development of new antiviral therapies.
丝状病毒(埃博拉病毒 [EBOV] 和马尔堡病毒 [MARV])是人畜共患的新兴病原体,可导致散发性和
全球爆发人类和非人类灵长类动物严重出血热。由于 EBOV 和 MARV 可以
在中枢神经系统、精液、眼睛和其他难以进入的免疫特权部位建立持续感染
抗体疗法,它们的重新出现可能导致长期后遗症和死亡,了解宿主
可能导致新抗病毒疗法开发的防御机制比以往任何时候都更加重要。我们的
实验室处于鉴定与丝状病毒在物理和功能上相互作用的宿主蛋白的最前沿
VP40 基质蛋白,病毒组装和排出的驱动力,调节病毒的这些后期阶段
复制。为了更好地了解功能性丝状病毒-宿主相互作用组,我们的实验室重点关注直接
EBOV (eVP40) VP40 蛋白中保守的 PPxY Late (L) 结构域基序与
MARV (mVP40) 和来自选定宿主蛋白的模块化 WW 结构域。除了丝状病毒的正调节因子
出口,我们最近发现了 WW 域相互作用子,它可以负向调节 VP40 介导的出芽,
包括 YAP/TAZ、BAG3 和 WWOX。虽然这些负面监管机构的影响可能是多因素的,
复杂的情况下,我们进行了有趣的观察,Filamin B 是 YAP/TAZ 的常见下游效应子
和 BAG3,充当活 EBOV/MARV 感染性/进入和活 EBOV/MARV 出口的潜在双重调节器。
由于丝状病毒生命周期两端关键阶段的双重作用调节是新颖且出乎意料的,
该提案的最终目标是确定宿主蛋白细丝蛋白 B 如何机械地影响丝状病毒
生命周期。细丝蛋白是肌动蛋白交联/稳定蛋白家族,可调节血浆肌动蛋白动力学
膜控制细胞迁移和形态、囊泡运输、巨胞饮作用和细胞分裂。
值得注意的是,巨胞饮作用
大胞质体
是
(MP) 紧密包裹有肌动蛋白、细丝蛋白和细丝蛋白相关蛋白
丝状病毒的关键进入途径,因为这些病毒通过囊泡进入细胞
称为
。此外,
细丝蛋白与模拟病毒颗粒形成和/或排出的细胞过程有关,例如丝状伪足形成,
细胞迁移和胞质分裂。因此,我们假设细丝蛋白 B 调节丝状病毒的感染性/进入
通过影响巨胞饮作用,并通过影响丝状伪足样的出口来调节丝状病毒出芽
丝状病毒颗粒。在这个探索性提案中,我们建议研究细丝蛋白的机制
调节丝状病毒感染性/进入(目标 1)和外出(目标 2)。这些研究的结果将影响该领域
鉴定一种新的宿主蛋白,其表达调节丝状病毒中两个关键且相反的步骤
生命周期;进入和退出,以及提供对功能性丝状病毒宿主的更好的基本了解
相互作用组和宿主防御机制可能导致新的抗病毒疗法的开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD N HARTY其他文献
RONALD N HARTY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD N HARTY', 18)}}的其他基金
Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
针对严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) 的面向宿主的疗法的开发,
- 批准号:
10688262 - 财政年份:2022
- 资助金额:
$ 26.83万 - 项目类别:
Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
针对严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) 的面向宿主的疗法的开发,
- 批准号:
10545109 - 财政年份:2022
- 资助金额:
$ 26.83万 - 项目类别:
Role of Host Angiomotin as a Central Regulator of Filovirus Egress and Dissemination
宿主血管动蛋白作为丝状病毒排出和传播的中央调节剂的作用
- 批准号:
10380684 - 财政年份:2021
- 资助金额:
$ 26.83万 - 项目类别:
Role of Host Angiomotin as a Central Regulator of Filovirus Egress and Dissemination
宿主血管动蛋白作为丝状病毒排出和传播的中央调节剂的作用
- 批准号:
10217843 - 财政年份:2021
- 资助金额:
$ 26.83万 - 项目类别:
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
针对出血热病毒的小分子疗法的开发
- 批准号:
10257889 - 财政年份:2018
- 资助金额:
$ 26.83万 - 项目类别:
Modular Domains of Host Proteins Regulate Filovirus Maturation
宿主蛋白的模块化结构域调节丝状病毒成熟
- 批准号:
9517218 - 财政年份:2018
- 资助金额:
$ 26.83万 - 项目类别:
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
针对出血热病毒的小分子疗法的开发
- 批准号:
10368115 - 财政年份:2018
- 资助金额:
$ 26.83万 - 项目类别:
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
针对出血热病毒的小分子疗法的开发
- 批准号:
10599837 - 财政年份:2018
- 资助金额:
$ 26.83万 - 项目类别:
DEVELOPMENT OF SMALL MOLECULE THERAPEUTICS AGAINST RNA VIRUSES
针对 RNA 病毒的小分子疗法的开发
- 批准号:
8903846 - 财政年份:2015
- 资助金额:
$ 26.83万 - 项目类别:
Innate Immune Regulation of Intracellular Pathways Involved in Filovirus Budding
丝状病毒出芽涉及的细胞内途径的先天免疫调节
- 批准号:
8635498 - 财政年份:2013
- 资助金额:
$ 26.83万 - 项目类别:
相似国自然基金
微波消融联合抗PD-1抗体治疗对肺癌肿瘤组织内类干细胞样CD8+T细胞的功能影响及其调控机制研究
- 批准号:82072028
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
CCR2拮抗剂与PD-1抗体联合治疗对于去势抵抗前列腺癌免疫环境影响的机制研究
- 批准号:81902618
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
HTRA1基因对湿性年龄相关性黄斑变性表型和疗效的影响及机制研究
- 批准号:81070760
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
CD34scFv介导的siRNA靶向抑制白血病干细胞AML1/ETO基因表达及其对细胞生长和分化的影响
- 批准号:30570784
- 批准年份:2005
- 资助金额:25.0 万元
- 项目类别:面上项目
单克隆抗体及其介导的nm23-H1基因转染对胃癌转移影响
- 批准号:39570339
- 批准年份:1995
- 资助金额:8.0 万元
- 项目类别:面上项目
相似海外基金
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 26.83万 - 项目类别:
Fibrosis, inflammation, and osteophyte formation in post-traumatic osteoarthritis
创伤后骨关节炎中的纤维化、炎症和骨赘形成
- 批准号:
10570315 - 财政年份:2023
- 资助金额:
$ 26.83万 - 项目类别:
Regulation of Ku70 methylation and functions by SETD4
SETD4 对 Ku70 甲基化和功能的调节
- 批准号:
10546482 - 财政年份:2021
- 资助金额:
$ 26.83万 - 项目类别:
The role of macrophage podosomes in Ebola virus pathogenesis
巨噬细胞足体在埃博拉病毒发病机制中的作用
- 批准号:
10301361 - 财政年份:2020
- 资助金额:
$ 26.83万 - 项目类别:
The role of ARF6 in the progression of diabetic kidney disease
ARF6在糖尿病肾病进展中的作用
- 批准号:
10412980 - 财政年份:2019
- 资助金额:
$ 26.83万 - 项目类别: